Ryan Welter
Family Medicine · North Attleboro, MANPI 1124198502
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 51 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 17.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $812 and has fallen 72.4% since, to $224 in 2025. Among family medicine clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 51 payments — averaging $42.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$369
- Arcutis Biotherapeutics, Inc.$255
- Merz North America, Inc.$252
- Revance Therapeutics, Inc.$180
- GSK$177
- E.r. Squibb & Sons, L.L.C.$127
- plus $813 from 16 others
Across 6 payments — averaging $2308.08 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$10K
- Kowa Research Institute, Inc.$2K
- AstraZeneca$1K
What the payments were for
- Food & beverage$2,173100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 4 | $369 |
| Arcutis Biotherapeutics, Inc. | 2 | $255 |
| Merz North America, Inc. | 2 | $252 |
| Revance Therapeutics, Inc. | 6 | $180 |
| GSK | 5 | $177 |
| E.r. Squibb & Sons, L.L.C. | 1 | $127 |
| Paratek Pharmaceuticals, Inc. | 1 | $125 |
| Vanda Pharmaceuticals Inc. | 4 | $119 |
| Novo Nordisk | 5 | $101 |
| Arteriocyte Medical Systems, Inc. | 1 | $85 |
| Incyte Corporation | 1 | $67 |
| UCB, Inc. | 2 | $54 |
| Pfizer | 5 | $46 |
| Sanofi-aventis U.S. LLC | 2 | $37 |
| Biofrontera Inc. | 2 | $37 |
| Lilly USA, LLC | 2 | $34 |
| AstraZeneca | 1 | $22 |
| VBI Vaccine (delaware) Inc. | 1 | $20 |
| Regeneron Healthcare Solutions, Inc. | 1 | $20 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $18 |
| Solta Medical, A Division Of Bausch Health US, LLC | 1 | $15 |
| Alkermes, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,173 in reported general payments places this provider in the 90th percentile of 1,049 family medicine providers in Massachusetts.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Minoxidil | 28 | $582 |
| Amlodipine Besylate | 17 | $273 |
| Atorvastatin Calcium | 27 | $171 |
| Losartan Potassium | 12 | $116 |
| Lisinopril | 11 | $104 |
| Citalopram HbrCitalopram Hydrobromide | 12 | $13 |
Paid to pharmacies, not to this prescriber.
Other family medicine in North Attleboro
- Lisa BowieNorth Attleboro$4K
- Larry CulpepperBoston$109K
- Jennifer WeylerWorcester$105K
- Megan McCoyFramingham$75K
- Kristina GraceyWorcester$73K
- Suzanne MitchellBoston$69K
- John GrievesonLowell$24K
- James SalemisRoslindale$24K
- David FarzanLawrence$23K
- Julie JohnstonLawrence$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.